SCHEMBL23958227

SCHEMBL23958227

Cc1cc2nc(Nc3cccnc3)n(-c3ccccc3)c(=O)c2cn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX12 P18054 1/20 0.46
MDM2 Q00987 1/20 0.43
PSD A5PKW4 1/20 0.42
KMT2A Q03164 2/20 0.41
RAD52 P43351 1/20 0.41
MAPT P10636 5/20 0.41
G6PD P11413 1/20 0.40
LOXL3 P58215 1/20 0.40
LOXL2 Q9Y4K0 1/20 0.40
PDE7A Q13946 1/20 0.39
CYP1A2 P05177 2/20 0.39
AHR P35869 1/20 0.39
MEN1 O00255 1/20 0.39
USP2 O75604 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
CLK4 Q9HAZ1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24111020 0.92 ALOX12 (0.46) ALOX12MDM2PSDKMT2ARAD52
SCHEMBL23958124 0.86 MDM2 (0.51) ALOX12MDM2PSDMAPTG6PD
SCHEMBL24110973 0.85 ALOX12 (0.47) ALOX12MDM2PSDKMT2ARAD52
SCHEMBL30103264 0.85 MDM2 (0.49) ALOX12MDM2PSDKMT2ARAD52
SCHEMBL23958215 0.85 MDM2 (0.49) ALOX12MDM2PSDKMT2ARAD52
SCHEMBL24110995 0.84 ALOX12 (0.57) ALOX12MDM2PSDKMT2ARAD52
SCHEMBL24111000 0.82 ALOX12 (0.49) ALOX12MDM2PSDKMT2ARAD52
SCHEMBL24111074 0.82 ALOX12 (0.45) ALOX12MDM2PSDKMT2ARAD52
SCHEMBL24110997 0.81 ALOX12 (0.41) ALOX12MDM2PSDKMT2ARAD52
SCHEMBL24110981 0.81 ALOX12 (0.43) ALOX12MDM2PSDKMT2ARAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2021-12-16 US disclosed
WO-2021215537-A1 2-HETEROARYLAMINOQUINAZOLINONE DERIVATIVE 大日本住友製薬株式会社 (JP) 2021-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE CRKL, CLIC4, CLIC1 ALOX12 3240/4885MDM2 4089/4885PSD 4499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.